Completed PHASE2 INTERVENTIONAL 2-arm NCT01330433

Effects of CoSeal on Bleeding & Adhesions in Pediatric Heart Surgery

Effects of CoSeal in Reducing Perioperative Bleeding & Adhesions in Pediatric Heart Surgery

Sponsor: Baxter Healthcare Corporation

Conditions Congenital Heart Defect Hemorrhage Surgery-Induced Tissue Adhesions

Interventions CoSeal Surgical Spray Group

Updated 6 times since 2017 Last updated: Oct 24, 2016 Started: Aug 31, 2011 Primary completion: Aug 31, 2015 Completion: Aug 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01330433, this PHASE2 trial focuses on Congenital Heart Defect and Hemorrhage and remains completed. Sponsored by Baxter Healthcare Corporation, it has been updated 6 times since 2011, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Aug 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baxter Healthcare Corporation
Loma Linda University

Data source: Loma Linda University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Loma Linda, United States